lsx

Name

lsx

Legal name

LSX Limited

Website

https://biotechandmoney.com

Company type

Private

Operating status

Operating

Ownership category

akta.pro rank

Product category

Life Sciences Events and Networking

NAICS

Newspaper, Periodical, Book, and Directory Publishers (5131)

SIC

Miscellaneous Publishing (2741)

akta.pro primary industry

Finance & Investment Conferences (MPAGAGAG)

akta.pro secondary industries

Life Sciences & Biotechnology Congresses (THAHAJAB), Executive Summits & Invitation-Only Forums (MPAGAGAK)

Keywords

• Life sciences events
• Executive networking
• Biotech conferences
• Investor relations
• Deal-making facilitation

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Event Registration and Sponsorship: Revenue generated through paid event attendance, conference sponsorships, and premium membership tiers for the life science executive community.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

LSX organizes and hosts life sciences conferences, executive forums, networking events, and an online investor community serving senior decision makers at biotech, medtech, and pharmaceutical companies and life science investors. Revenue is generated through paid event registration, conference sponsorships, and annual premium memberships that unlock the Investor Portal and exclusive networking opportunities.

Product overview

LSX (formerly Biotech and Money) is a community and events platform for senior life science decision makers. The company operates as a multi-brand portfolio including flagship conferences (Biotech and Money World Congress, Medtech and Money World Congress), regional events (LSX Nordic Congress, LSX World Congress USA), executive forums (LSX European CEO Forum), networking events (LSX Connect), and the LSX Investor Club. Supporting content products include the Drugs & Dealers Blog, Investorviews interview series, Executive Publications and Reports, Featured Videos, and Deals Watch market intelligence. The platform connects life science corporates with investors through events, thought leadership content and structured partnering opportunities.

Differentiator

Problem solved

Functional benefit

Brands

• Medtech and Money: Event brand focused on medtech sector alongside the Biotech and Money World Congress
• Investival Showcase
• Inv€$table Showcases
• LSX Nordic Congress
• LSX World Congress USA
• LSX CEO Forum
• LSX Connect
• LSX Investor Club
• World HealthEx Forum
• Drugs & Dealers
• Investorviews
• Deals Watch

Products and services

• Biotech and Money / LSX Community Platform An influential community platform for senior life science decision makers providing networking, thought leadership content, and deal-making facilitation across the healthcare investment sector.
• Biotech and Money World Congress Two-day flagship UK annual congress for C-level biopharma executives providing insight, strategies, and tactics for funding, investment and partnering, featuring keynote sessions, group discussions, interactive roundtables, showcases and structured 1-2-1 partnering.
• Medtech and Money World Congress World congress event focused on medtech sector investment, partnering and deal-making for senior executives.
• Inv€$table Showcases Presentation showcases providing space for 55+ biotech and medtech companies to present their vision, track record and future plans to investors over a 2-day event.
• LSX Nordic Congress High-calibre senior executive conference and partnering event at Nasdaq Stockholm providing education, strategies and contacts for effective investment, business planning and partnering within life science businesses.
• LSX World Congress USA Two-day senior executive conference and partnering event at One Boston Place, Convene, Boston, MA providing education, strategies and contacts for effective funding, investment, planning and growth within life science businesses.
• LSX European CEO Forum 40-person Chatham House Rule formatted forum for CEOs and CFOs from innovative life science companies to discuss and shape the future of their sector behind closed doors in a hollow-square format.
• LSX Connect Networking event for senior life science executives - a 3-hour evening function serving as an informal forum for up to 70 executives to network and enjoy presentations or panels.
• LSX Investor Club Exclusive investor community within the LSX network for connecting with capital and deal-making opportunities.
• World HealthEx Forum Dynamic outcome-oriented summit for C-suite and board level executives from pharma, health technology, finance and government dedicated to finding solutions to health industry challenges through debate, dialogue and collaboration.
• Drugs & Dealers Blog Thought leadership blog providing executive insight into the life science and healthcare investment sector with articles on deals, biotech news and investment analysis.
• Investorviews Interview series featuring some of the most interesting and active investors in the life science investment community.
• Executive Publications and Reports Knowledge resources including investor perception surveys, guides to investment in advanced therapies, sector analysis reports and infographics on life sciences investment.
• Featured Videos Video interviews and recordings featuring life science executives, investors and industry leaders discussing topics such as advanced therapies, Brexit impact, and investment challenges.
• Deals Watch Monthly review of top deals by value in the healthcare sector, produced in partnership with Medius Associates.
• Premium Membership Premium membership offering exclusive access to the senior life science executive community, enhanced networking opportunities and privileged content including the Investor Portal.

Quantifiable outcome

• 360+ senior executives at flagship London events
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

17 partnerships are on record, tiered community partner, content partner, regional partner and venue partner.

• Alacritacommunity partnerOthersConsulting and advisory firm specializing in life sciences, listed as community partner providing expertise to LSX network
• Allen & Overycommunity partnerOthersInternational law firm with life sciences practice, community partner supporting LSX events
• Appleyard Leescommunity partnerOthersIntellectual property law firm specializing in life sciences, community partner
• Boult Wade Tennantcommunity partnerOthersIntellectual property firm, community partner
• Cancer Research UKcommunity partnerOthersLeading cancer research charity, community partner
• Capitalcellcommunity partnerOthersEquity crowdfunding platform for life sciences, community partner
• CMS Cameron McKennacommunity partnerOthersLaw firm providing office space for events and supporting as community partner
• Covington & Burlingcommunity partnerOthersInternational law firm with life sciences expertise, community partner
• EQScommunity partnerOthersRegulatory and compliance services firm, community partner
• Gallaghercommunity partnerOthersInsurance and risk management firm, community partner
• Gill Jennings & Everycommunity partnerOthersPatent and trademark attorney firm, community partner
• Horizon Discoverycommunity partnerOthersLife science tools company, community partner
• Marks & Clerkcommunity partnerOthersIntellectual property services firm, community partner
• Xplicocommunity partnerOthersTechnology/IP services firm, community partner
• Medius Associatescontent partnerOthersDeal Watch monthly review partnership covering top healthcare deals by value
• NYCEDCregional partnerStrategic or Co-development PartnerNew York City Economic Development Corp partnership for NYC life science ecosystem development
• Nasdaq Stockholmvenue partnerOthersStock exchange hosting LSX Nordic Congress events

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• EBD Group: EBD Group runs the BIO Partnering platform and a series of life sciences partnering conferences (BIO-Europe, BIO-Europe Spring, BIO Asia) that closely mirror LSX's flagship congress model in serving biotech BD&L and investor deal-making.
• BioCentury: BioCentury is a long-standing life sciences media and events business producing editorial intelligence, investor conferences, and partnering platforms targeted at the same biotech investor and corporate executive audience as LSX.
• Cambridge Healthtech Institute (CHI): CHI produces large-scale life sciences and biotech conferences with partnering components serving pharma, biotech, and investor communities in direct overlap with LSX's flagship congress offerings.

Broad incumbents

• BIO (Biotechnology Innovation Organization): BIO is the largest global biotech industry association, organizing the BIO International Convention and partnering forums that dwarf LSX's flagship events in attendance and serve overlapping biotech executive and investor audiences.
• Informa (Pharma & Life Sciences events): Informa runs extensive life sciences event franchises (CBI, Pharma Intelligence, BioEurope-adjacent properties) and competes with LSX in the same senior executive BD&L and investor audience across multiple geographies.

Emerging players

• Endpoints News: Endpoints is a digital biotech news and events platform that increasingly hosts investor and executive gatherings, competing with LSX for senior life science executive attention and sponsorship budgets.
• Fierce Biotech / Fierce Pharma Events: Fierce Biotech operates editorial and event franchises focused on biopharma executives, with conferences that intersect LSX's senior executive community and investor focus.

Regional players

• PharmaTimes: PharmaTimes runs UK-anchored life sciences awards, publications, and events serving pharma and biotech executives, with a regional overlap with LSX's London-centric operations.
• MedCity: MedCity is a London-based life sciences cluster organization promoting UK biotech investment and partnering, with mission overlap with LSX's UK executive networking and partnership positioning.

Others

• Jefferies (Healthcare Conference): Jefferies is a listed investment bank that runs an annual Global Healthcare Conference and partners with LSX on Investival Showcases, making it both a strategic partner and an indirect competitor for healthcare investor mindshare.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/BiotechandMoney
• YouTubeyoutube.com/channel/UCBjBilvMaUhkgWLjQ95NIQg
• Facebookfacebook.com/LSXGlobal
• LinkedInlinkedin.com/groups/7494573

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about lsx